The health and safety of our patients, families and staff is our highest priority. Due to the COVID-19 pandemic, the Commonwealth of Massachusetts is requiring hospitals to meet established criteria as part of the state’s reopening plan. The Boston Shriners Hospital completed its Phase 1 attestation on May 27, 2020, and its Phase 2 attestation on June 15, 2020 and its Phase 3 attestation on July 13, 2020. The Phase 3 attestation was resubmitted and reaffirmed on November 16, 2020. The Boston Shriners Hospital also completed and submitted the state’s resurgence attestation on November 16, 2020.

If your child has an upcoming appointment, please contact your local Shriners Hospitals for Children location.

Shriners Hospitals for Children — Boston visitor information.

Skip to navigation

Daniel Irimia, M.D., Ph.D.

Daniel Irimia, M.D., Ph.D., is a senior investigator at Shriners Hospitals for Children — Boston, and deputy director for the Nano-Micro shared facility that advances the use of nano and microscale technologies in biomedical research at the Boston Shriners Hospital. Dr. Irimia is especially interested in early diagnosis of sepsis and bacteremia in burn and trauma patients. He is currently leading an ongoing clinical study in this area.

Dr. Irimia’s research focus is the study of the role of neutrophils and immune system in the context of burn injury. He has recently designed a microfluidic device that can diagnose sepsis in burn patients with unprecedented accuracy. He leads a team of scientists and medical doctors that employ these devices to monitor burn patients, optimize treatments, and uncover neutrophil-targeting interventions that could prevent infections and sepsis in burn patients.

Dr. Irimia has published 100 journal articles in top tier journals such as Nature Materials, Nature Communications and Proceedings of the National Academy of Sciences.

Dr. Irimia is the organizer of the Dicty World Cell Races, which encourages biologists to employ novel microfluidic tools in research on cell chemotaxis and achieve the level of precision and detail that are not currently possible using any other tools. These efforts brought Dr. Irimia’s work to the front page of Wall Street Journal (March 2014), and in the news of the American Society for Cell Biology. Dr. Irimia is also a member of Leukocyte Biology Society. His works have garnered media coverage in magazines including Nature, Wired, Science in Schools and Chemical and Engineering News.

Dr. Irimia is the recipient of numerous awards including:

  • Pioneers of Miniaturization award in 2016 for extraordinary contributions to the understanding or development of miniaturized systems

Current positions:

  • Scientific Staff, Senior Investigator, Shriners Hospitals for Children — Boston
  • Associate Professor, Harvard Medical School
  • Associate Professor, Massachusetts General Hospital


  • M.D., Grigore T. Popa Medical School, Iasi, Romania
  • Ph.D., Bioengineering, University of Illinois at Chicago

Scholarly activities: